Abstract:Staphylococci, notably biofilm-forming Staphylococcus epidermidis, have been recognized as global nosocomial pathogens in medical device-related infections. Their potential to attach to and form biofilm on indwelling catheters are significant factors impeding conventional treatment. Due to their extensive antimicrobial and antibiofilm actions, antimicrobial peptides (AMPs) have attracted interest as promising alternative compounds for curing difficult-to-treat, biofilm-forming bacterial infections. Cecropin A-melittin or CM, a well-known hybrid peptide, exhibits broad-spectrum antimicrobial activity, however it also possesses high toxicity. In the current study, a series of hybrid CM derivatives was designed using an amino acid substitution strategy to explore potential antibacterial and antibiofilm peptides with low toxicity. Among the derivatives, CM-10K14K showed the least hemolysis along with potent antibacterial activity against biofilm-forming S. epidermidis (MICs = 3.91 μg/mL) and rapid killing after 15 min exposure (MBCs = 7.81 μg/mL). It can prevent the formation of S. epidermidis biofilm and also exhibited a dose-dependent eradication activity on mature or established S. epidermidis biofilm. In addition, it decreased the development of biofilm by surviving bacteria, and formation of biofilm on the surface of CM-10K14K-impregnated catheters. Released CM-10K14K decreased planktonic bacterial growth and inhibited biofilm formation by S. epidermidis in a dose-dependent manner for 6 and 24 h post-exposure. Impregnation of CM-10K14K prevented bacterial attachment on catheters and thus decreased formation of extensive biofilms. SEM images supported the antibiofilm activity of CM-10K14K. Flow cytometry analysis and TEM images demonstrated a membrane-active mechanism of CM-10K14K, inducing depolarization and permeabilization, and subsequent membrane rupture leading to cell death. The presence of an interaction with bacterial DNA was verified by gel retardation assay. These antibacterial and antibiofilm activities of CM-10K14K suggest its potential application to urinary catheters for prevention of biofilm-forming colonization or for treatment of medical devices infected with S. epidermidis.

Design, Recombinant Expression, and Antibacterial Activity of the Cecropins–Melittin Hybrid Antimicrobial Peptides

Functional Analysis of Hybrid Peptide CAMA-Syn: Expression in Mammalian Cells and Antimicrobial Potential

[Synthesis of Hybrid Antimicrobial Peptide CecA-mag Gene and It's Secretion Expression in Pichia Pastoris].

Novel Hybrid Peptide Cecropin A (1–8)-LL37 (17–30) with Potential Antibacterial Activity

Hybridization with Insect Cecropin A (1–8) Improve the Stability and Selectivity of Naturally Occurring Peptides

Synthesis and secretory expression of hybrid antimicrobial peptide CecA-mag and its mutants in Pichia pastoris.

Cecropin A-Melittin Mutant with Improved Proteolytic Stability and Enhanced Antimicrobial Activity Against Bacteria and Fungi Associated with Gastroenteritis in Vitro

Design of Hybrid Β-Hairpin Peptides with Enhanced Cell Specificity and Potent Anti-Inflammatory Activity.

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Antibacterial Activity and Mechanism of a Bacteriocin Derived from the Valine-Cecropin A(1–8)-Plantaricin ZJ5(1–18) Hybrid Peptide Against Escherichia coli O104

Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity

Modification of Hybrid Antimicrobial Peptide CecA-mil Gene and Its Over-Secretion Expression in Pichia Pastoris

Molecular design and antibacterial activity of cecropin-like antibacterial peptide

The bactericidal and antibiofilm effects of a lysine-substituted hybrid peptide, CM-10K14K, on biofilm-forming Staphylococcus epidermidis

Prokaryotic Expression and Activity Identification of Hybrid Peptide HMCM

The Molecular Design of a Recombinant Antimicrobial Peptide CP and Its in Vitro Activity

Efficient biosynthesis of a Cecropin A-melittin mutant in Bacillus subtilis WB700

High-level expression of a hybrid antimicrobial peptide LfcinB-Cecropin in Escherichia coli and its activity

Design, Synthesis and Antimicrobial Activity of an Hybrid Antimicrobial Peptide LFB15-MA12.

Novel CA(1-7)M(2-9) Analogs: Synthesis, Characterization, and Antibacterial Evaluation

Secreted Expression and Activity Detection of Two Hybrid Antimicrobial Peptides in Pichia Pastoris